Lonza opens vitamin K3 plant in Canada

Since acquiring the assets of SAM Electron Technologies last May, the new
Canadian division of Lonza proceeded with investments of nearly CAN$ 2 million
to increase production capacity and acquire new equipment.

“Welcome to
the first factory to produce vitamin K3 in North America, the first factory to
produce vitamin K3 in the world based on the ecological edge,” said Behzad
Mahdavi, director of the site and senior director of business development for
Lonza Canada, at the opening of the site.

New
brand
Vitamin K3 produced in Shawinigan will be marketed through a
new brand of Lonza, Pro-K, characterized by the production technology yet
unpublished, CeTECH, of which Lonza holds the worldwide license. Pro-K is
produced amongst others using coagulation technology. “This is a new technology
that is so crucial in relation to the technology currently used. It is a
technology that is extremely clean, green, and very competitive, “Mahdavi said.
Lonza leaders make no secret of wanting to expand the horizons of technology
CeTECH to other applications.

About Lonza
Lonza is
headquartered in Switzerland, in Basel, and operates production units in
Switzerland, China, the Czech Republic and the United States. Its revenues for
the year 2006 amounted to CAN$2.9 billion.

Related
website:
Lonza

To receive more animal feed news, subscribe
here